Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted mri with gadolinium-enhanced MRI using liver explantation standard

Journal of Computer Assisted Tomography

Volumn 35, Issue 6, 2011, Pages 711-715

  Hardie, Andrew D ^a   Kizziah, Michael K ^a   Rissing, Michael S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cirrhosis; diffusion weighted MRI; gadolinium; hepatocellular carcinoma

Indexed keywords

DIAGNOSIS; DIFFUSION; GADOLINIUM; HOSPITAL DATA PROCESSING; PATHOLOGY;

CIRRHOSIS; DATA SET; DIFFUSION-WEIGHTED MAGNETIC RESONANCE; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; GADOLINIA; HEPATOCELLULAR CARCINOMA; IMAGING PROTOCOL; REFERENCE STANDARD; STAND -ALONE; T2 WEIGHTED;

MAGNETIC RESONANCE IMAGING;

GADOLINIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; EXPLANT; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 81355142175     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31823421ac     Document Type: Article

References (15)

1. Semelka RC, Martin DR, Balci C, et al. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging. 2001;13:397-401. (Pubitemid 32173407)
2. Hecht EM, Holland AE, Israel GM, et al. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a standalone sequence for diagnosis. Radiology. 2006;239:438-447.
3. Leiner T, Kucharczyk W. NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe. J Magn Reson Imaging. 2009;30:1357-1363.
4. Kelekis NL, Semelka RC, Worawattanakul S, et al. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol. 1998;170:1005-1013. (Pubitemid 28172890)
5. Hardie AD, Romano PB. The use of T2*-weighted multi-echo GRE imaging as a novel method to diagnose hepatocellular carcinoma compared with gadolinium-enhanced MRI: a feasibility study. Magn Reson Imaging. 2010;28:281-285.
6. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, et al. Respiratory gated diffusion weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol. 2008;18:486-492.
7. Nishie A, Tajima T, Ishigami K, et al. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)Yenhanced MRI: added value of diffusion-weighted imaging (DWI). J Magn Reson Imaging. 2010;31:373-382.
8. Vandecaveye V, De Keyzer F, Verslype C, et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol. 2009;19:2456-2466.
9. Xu PJ, Yan FH, Wang JH, et al. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging. 2009;29:341-349.
10. Dobritz M, Radkow T, Nittka M, et al. VIBE with parallel a cquisition techniqueVa novel approach to dynamic contrast-enhanced MR imaging of the liver [in German]. Rofo. 2002;174:738-741. (Pubitemid 34664170)
11. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (G or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology. 2005;237:938-944. (Pubitemid 41636384)
12. Hecht EM, Holland AE, Israel GM, et al. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology. 2006;239:438-447.
13. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983-993.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174. (Pubitemid 8054849)
15. Martin DR, Krishnamoorthy SK, Kalb B, et al. Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols. J Magn Reson Imaging. 2010;31(2):440-446.